查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1886015

全球幽門螺旋桿菌診斷市場

Helicobacter Pylori Diagnostics
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 158 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計2030年，全球幽門螺旋桿菌診斷市場規模將達9.641億美元。

2024年全球幽門螺旋桿菌診斷市場規模預估為7.28億美元，預估至2030年將達9.641億美元，在分析期間（2024-2030年）內複合年成長率（CAGR）為4.8%。本報告分析的細分市場之一－醫院終端用戶市場，預計複合年成長率為4.8%，到分析期末將達到4.369億美元。診斷中心終端用戶細分市場預計在分析期間內複合年成長率為5.1%。

美國市場規模估計為1.915億美元，而中國市場預計將以7.2%的複合年成長率成長。

據估計，2024年美國幽門螺旋桿菌診斷市場規模將達1.915億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到2.1億美元，在2024年至2030年的分析期間內，複合年成長率（CAGR）為7.2%。其他值得關注的區域市場分析包括日本和加拿大，預計在分析期間內，兩國的複合年成長率分別為2.6%和4.4%。在歐洲，德國的複合年成長率預計約為2.8%。

全球幽門螺旋桿菌診斷市場—主要趨勢與促進因素摘要

幽門螺旋桿菌感染的診斷對腸道健康重要嗎？

幽門螺旋桿菌（H. pylori）的診斷在胃腸道健康管理中日益重要，但為什麼診斷這種細菌如此重要？幽門螺旋桿菌廣泛存在於胃黏膜中，是多種消化系統疾病的主要原因，包括胃炎、消化性潰瘍，在某些情況下甚至會導致胃癌。由於幽門螺旋桿菌能夠在胃部的強酸性環境中生存，因此即使不進行治療，感染也可能持續多年，可能導致慢性消化系統疾病和長期健康問題。早期準確檢測對於預防這些疾病的進展至關重要。

診斷幽門螺旋桿菌感染疾病至關重要，因為其症狀常與其他胃腸道疾病相似，若不進行特異性檢測則難以確診。由於腹痛、腹脹、噁心和消化不良等症狀通用於多種胃腸道疾病，因此準確診斷有助於將幽門螺旋桿菌感染與其他病因區分開來。目前有多種幽門螺旋桿菌檢測方法，包括血液檢測、糞便檢驗和呼吸檢測等非侵入性檢測，以及內視鏡檢查和切片檢查等侵入性檢測。雖然每種檢測方法的準確性因具體情況而異，但早期發現是預防嚴重併發症的關鍵。隨著人們對幽門螺旋桿菌與嚴重胃腸道疾病之間關聯的認知不斷提高，準確診斷對於有效治療和管理的重要性也日益凸顯。

技術如何改善幽門螺旋桿菌的診斷？

技術進步顯著提高了幽門螺旋桿菌診斷的準確性、速度和便利性，為滿足各種臨床需求提供了更多選擇。其中一項最重要的創新是尿素呼吸檢測，它已成為目前應用最廣泛的非侵入性幽門螺旋桿菌感染檢測方法。此試驗的原理是測量患者服用尿素溶液後呼出氣體中的碳同位素。如果體內存在幽門螺旋桿菌，細菌會分解尿素，釋放出二氧化碳，而二氧化碳可以透過呼氣檢測出來。此方法結果高度準確，尤其適用於治療前後確認感染情況，使其成為侵入性檢測方法的可靠替代方案。

另一項重大進展是糞便抗原檢測，它可以檢測患者糞便樣本中的幽門螺旋桿菌蛋白。現代糞便抗原檢測具有高靈敏度和特異性，為診斷活動性性行為感染提供了一種便利、非侵入性的選擇。這些檢測在內視鏡檢查或呼吸檢測不易進行的地區尤其有用，其價格低廉且易於獲取，因此在臨床實踐中得到了越來越廣泛的應用。

內視鏡檢查和切片檢查等侵入性檢測方法也顯示出診斷準確性的提高。切片檢查技術和分子檢測技術的進步使得檢測幽門螺旋桿菌菌株的抗生素抗藥性成為可能，有助於制定更有效的治療策略。諸如聚合酵素鏈鎖反應（PCR）等分子診斷方法可以檢測導致幽門螺旋桿菌對常用抗生素產生抗藥性的特定基因，有助於應對因抗藥性菌株導致的治療失敗這一日益嚴峻的挑戰。這些技術進步提高了幽門螺旋桿菌的診斷效率，實現了更早期、更精準的檢測以及更有針對性的治療方案。

為什麼幽門螺旋桿菌診斷對公共衛生至關重要？

幽門螺旋桿菌的診斷對於公共衛生至關重要，因為這種細菌廣泛流行，且與嚴重的胃腸道疾病密切相關。據估計，全球超過一半的人口感染了幽門螺旋桿菌，但許多人並無症狀。然而，一旦出現症狀，感染可能導致嚴重的後果，包括慢性胃炎、消化性潰瘍，甚至在極端情況下會發展為胃癌。世界衛生組織（WHO）已將幽門螺旋桿菌列為1類致癌性，因為它與胃癌密切相關，因此早期檢測是降低這種致命疾病發生率的首要任務。

定期檢測至關重要，尤其是在胃腸道疾病高風險族群中，例如幽門螺旋桿菌感染率高或醫療資源匱乏的地區。早期診斷和治療幽門螺旋桿菌感染可以預防消化性潰瘍的發生，並顯著降低胃癌的風險，進而改善長期健康狀況。這在資源匱乏的國家尤其重要，因為胃癌仍然是這些國家癌症相關死亡的主要原因之一。

在臨床實踐中，診斷幽門螺旋桿菌感染對於治療反覆出現的胃腸道症狀至關重要，因為這些症狀常常被誤診為其他原因。慢性消化不良、胃炎或潰瘍患者通常接受安寧療護，而未針對潛在的細菌感染進行治療。如果沒有正確的診斷，這些患者可能會持續出現復發症狀，或隨著時間的推移而出現嚴重的併發症。準確的檢測能夠幫助臨床醫生提供標靶治療，根除感染並預防復發，從而改善患者預後並降低醫療成本。隨著人們對幽門螺旋桿菌在胃病中作用的認知不斷提高，診斷技術正成為旨在減輕全球胃腸道疾病負擔的公共衛生措施的基石。

哪些因素正在推動幽門螺旋桿菌診斷市場的成長？

幽門螺旋桿菌診斷市場的成長是由多種因素共同推動的，包括公眾意識的提高、技術的進步以及對有效管理胃腸道疾病需求的不斷成長。其中一個關鍵促進因素是人們日益認知到幽門螺旋桿菌感染與胃癌和消化性潰瘍等嚴重健康問題之間的關聯。隨著越來越多的醫療專業人員和公共衛生組織強調早期檢測和治療的重要性，對可靠且易於使用的診斷工具的需求正在飆升。在幽門螺旋桿菌感染率高的國家，這一點尤其明顯，因為篩檢和早期治療可以顯著降低胃癌的發生率。

技術進步也是推動市場成長的主要因素。諸如非侵入性尿素呼吸檢測和高精度糞便抗原檢測等創新技術，使幽門螺旋桿菌的診斷更加便捷，醫療機構無需進行侵入性操作篩檢和診斷感染。這些進步也使得患者更容易在門診或家中接受檢測，擴大了診斷服務的覆蓋範圍，並提高了早期發現的可能性。此外，PCR檢測等分子診斷技術的進步使得檢測抗藥性幽門螺旋桿菌菌株成為可能，有助於應對日益嚴峻的抗藥性挑戰，並提高根除治療的成功率。

抗藥性幽門螺旋桿菌菌株的增加也推動了對更先進診斷方法的需求。由於抗生素抗藥性使治療複雜化，因此在治療開始前檢測抗藥性菌株至關重要。透過識別抗藥性模式，這些診斷技術可以幫助醫生開立最有效的抗生素，從而降低治療失敗的風險並防止抗藥性細菌的傳播。隨著醫療系統在努力改善治療效果的同時對抗抗生素抗藥性，這種向精準醫療的轉變正在推動診斷市場的發展。

最後，人們對預防性醫療保健的日益重視正在推動對幽門螺旋桿菌診斷的需求。許多醫療保健系統已實施針對高風險族群的篩檢項目，旨在檢測和治療幽門螺旋桿菌感染，防止其發展為更嚴重的疾病。這種預防方法不僅能改善患者的治療效果，還能降低治療晚期胃病相關的長期醫療成本。隨著全球醫療保健趨勢繼續優先考慮早期檢測和精準治療，對準確且易於獲取的幽門螺旋桿菌診斷的需求預計將會增加，並成為醫療診斷市場的關鍵成長領域。

部分：

檢測類型（侵入性、非侵入性）、最終用途（醫院、診斷中心、診所）

受訪公司範例

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Cardinal Health, Inc.
  • DiaSorin SpA
  • Exalenz Bioscience Ltd.
  • F. Hoffmann-La Roche AG
  • Halyard Health, Inc.
  • Meridian Bioscience, Inc.
  • Quidel Corporation
  • Thermo Fisher Scientific, Inc.

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具，改變您分析市場和競爭情報的方式。

Market Glass, Inc. 並沒有採用查詢LLM 或產業專用的SLM 的典型方法，而是建立了一個由世界各地領域專家精心策劃的內容庫，其中包括影片文字稿、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

在最新發布的報告中，Market Glass, Inc. 將關稅對地理市場的影響納入考量，並根據公司總部所在地、製造地以及進出口（成品和OEM產品）情況，預測企業競爭地位的變化。這種複雜多變的市場現實會從多個方面影響競爭對手，包括增加銷貨成本、降低盈利和重組供應鏈，同時也會影響微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 亞太其他地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP12332

Global Helicobacter Pylori Diagnostics Market to Reach US$964.1 Million by 2030

The global market for Helicobacter Pylori Diagnostics estimated at US$728.0 Million in the year 2024, is expected to reach US$964.1 Million by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$436.9 Million by the end of the analysis period. Growth in the Diagnostics Centers End-Use segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$191.5 Million While China is Forecast to Grow at 7.2% CAGR

The Helicobacter Pylori Diagnostics market in the U.S. is estimated at US$191.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$210.0 Million by the year 2030 trailing a CAGR of 7.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Helicobacter Pylori Diagnostics Market - Key Trends and Drivers Summarized

Is Helicobacter Pylori Diagnostics Crucial for Stomach Health?

Helicobacter pylori (H. pylori) diagnostics are becoming increasingly important in the management of gastrointestinal health, but what makes diagnosing this bacteria so critical? H. pylori is a type of bacteria commonly found in the stomach lining and is the leading cause of various gastrointestinal disorders, including gastritis, peptic ulcers, and, in some cases, gastric cancer. Because of its ability to survive in the harsh acidic environment of the stomach, H. pylori infections can persist for years without treatment, leading to chronic digestive issues and long-term health complications. Early and accurate detection is essential to preventing the progression of these conditions.

Diagnosing H. pylori infections is crucial because symptoms can often mimic other gastrointestinal problems, making it difficult to identify without specific tests. Symptoms like abdominal pain, bloating, nausea, and indigestion are common in many digestive disorders, so accurate diagnostics help differentiate H. pylori infections from other causes. Tests for H. pylori range from non-invasive methods, such as blood tests, stool tests, and breath tests, to invasive procedures like endoscopy and biopsy. Each test offers varying degrees of accuracy, depending on the situation, but early detection is key in preventing severe complications. As awareness of H. pylori’s link to serious gastrointestinal diseases grows, the demand for precise diagnostics is becoming more critical to effective treatment and management.

How Has Technology Improved Helicobacter Pylori Diagnostics?

Technological advancements have significantly improved the accuracy, speed, and ease of Helicobacter pylori diagnostics, offering a range of options tailored to different clinical needs. One of the most significant innovations is the urea breath test, which has become one of the most widely used non-invasive methods for detecting H. pylori infections. This test works by measuring carbon isotopes in the breath after a patient ingests a urea solution. If H. pylori is present, the bacteria will break down the urea, releasing carbon dioxide that can be detected in the breath. This method provides highly accurate results and is particularly useful for confirming infection before and after treatment, offering a reliable alternative to more invasive testing.

Another major advancement is in stool antigen testing, which detects H. pylori proteins in a patient's stool sample. Modern stool antigen tests are highly sensitive and specific, offering a convenient, non-invasive option for diagnosing active infections. These tests are particularly valuable in areas where endoscopy or breath tests may not be readily available, and they are increasingly used in clinical settings due to their affordability and accessibility.

Invasive testing methods, such as endoscopy with biopsy, have also seen improvements in diagnostic accuracy. Advances in biopsy techniques and molecular testing now allow for the detection of antibiotic resistance in H. pylori strains, guiding more effective treatment strategies. Molecular diagnostics, such as PCR (polymerase chain reaction), can detect specific genes in H. pylori that confer resistance to commonly used antibiotics, helping to address the rising challenge of treatment failure due to drug-resistant strains. These technological breakthroughs have made H. pylori diagnostics more effective, enabling earlier and more precise detection and better-targeted treatment plans.

Why Are Helicobacter Pylori Diagnostics Essential for Public Health?

H. pylori diagnostics are essential for public health due to the bacteria’s widespread prevalence and its role in severe gastrointestinal diseases. It is estimated that over half of the global population is infected with H. pylori, though many remain asymptomatic. However, for those who do develop symptoms, the consequences can be serious, including chronic gastritis, peptic ulcers, and, in extreme cases, gastric cancer. The World Health Organization (WHO) has classified H. pylori as a Group 1 carcinogen due to its strong link to stomach cancer, making early detection a priority for reducing the incidence of this deadly disease.

Routine testing for H. pylori is particularly important in populations at high risk for gastrointestinal disorders, including regions where H. pylori infection rates are high or where access to healthcare is limited. Diagnosing and treating H. pylori infections early can prevent the development of peptic ulcers and significantly reduce the risk of stomach cancer, improving long-term health outcomes. This is especially important in countries with limited resources, where gastric cancer remains one of the leading causes of cancer-related deaths.

In clinical practice, diagnosing H. pylori is crucial for managing recurrent gastrointestinal symptoms that are often misattributed to other causes. Patients with chronic indigestion, gastritis, or ulcers are often treated symptomatically without addressing the underlying bacterial infection. Without proper diagnostics, these patients may continue to suffer from recurring symptoms or develop more serious complications over time. Accurate testing helps clinicians provide targeted treatments that eradicate the infection and prevent relapses, leading to better patient outcomes and reduced healthcare costs. As awareness of H. pylori's role in gastric diseases grows, diagnostics are becoming a cornerstone of public health initiatives aimed at reducing the global burden of stomach disorders.

What Factors Are Driving the Growth of the Helicobacter Pylori Diagnostics Market?

The growth in the Helicobacter pylori diagnostics market is driven by a combination of rising awareness, technological advancements, and increasing demand for effective management of gastrointestinal disorders. One of the primary drivers is the growing recognition of the link between H. pylori infection and serious health issues such as gastric cancer and peptic ulcers. As more healthcare professionals and public health organizations emphasize the importance of early detection and treatment, the demand for reliable, accessible diagnostic tools has surged. This is particularly true in countries with high H. pylori infection rates, where screening and early treatment can significantly reduce the incidence of gastric cancer.

Technological advancements are another major factor propelling market growth. Innovations such as non-invasive urea breath tests and highly accurate stool antigen tests have made H. pylori diagnostics more accessible and convenient, allowing healthcare providers to screen and diagnose infections without the need for invasive procedures. These advancements have made it easier for patients to be tested in outpatient or even home settings, broadening the reach of diagnostic services and increasing the likelihood of early detection. In addition, the development of molecular diagnostics, such as PCR tests, allows for the detection of antibiotic-resistant H. pylori strains, helping to combat the growing problem of treatment resistance and improve the success rates of eradication therapies.

The increasing prevalence of drug-resistant H. pylori strains is also driving demand for more advanced diagnostics. As antibiotic resistance continues to complicate treatment, the need for tests that can detect resistant strains before treatment is initiated has become critical. By identifying resistance patterns, these diagnostics help physicians prescribe the most effective antibiotics, reducing the likelihood of treatment failure and preventing the spread of resistant bacteria. This shift toward precision medicine is driving growth in the diagnostics market as healthcare systems seek to improve treatment outcomes while combating antibiotic resistance.

Lastly, the growing focus on preventive healthcare is pushing the demand for H. pylori diagnostics. Many health systems are adopting screening programs aimed at high-risk populations to detect and treat H. pylori infections before they lead to more severe diseases. This preventive approach not only improves patient outcomes but also reduces the long-term healthcare costs associated with treating advanced gastric diseases. As global healthcare trends continue to prioritize early detection and precision treatment, the demand for accurate and accessible H. pylori diagnostics is set to rise, making it a critical area of growth in the medical diagnostics market.

SCOPE OF STUDY:

The report analyzes the Helicobacter Pylori Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Test Type (Invasive, Non-Invasive); End-Use (Hospitals, Diagnostics Centers, Clinics)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 12 Featured) -

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Cardinal Health, Inc.
  • DiaSorin SpA
  • Exalenz Bioscience Ltd.
  • F. Hoffmann-La Roche AG
  • Halyard Health, Inc.
  • Meridian Bioscience, Inc.
  • Quidel Corporation
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Global Economic Update
    • Helicobacter Pylori Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Helicobacter Pylori Infections Drives Demand for Diagnostic Solutions
    • Growth in Gastrointestinal Disease Screening Expands Addressable Market for H. Pylori Diagnostics
    • Increasing Focus on Early Detection and Treatment of Peptic Ulcers Spurs Adoption of H. Pylori Testing
    • Growth in Use of Urea Breath Tests (UBT) for Non-invasive H. Pylori Detection Drives Adoption
    • Increasing Demand for Point-of-care Testing Solutions Expands Market for H. Pylori Diagnostics
    • Expansion of Diagnostic Laboratories and Healthcare Facilities Boosts Availability of H. Pylori Testing
    • Market Dynamics Driven by Rising Prevalence of Antibiotic-resistant Strains of H. Pylori
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Diagnostics Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Diagnostics Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Diagnostics Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Invasive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Non-Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Non-Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Non-Invasive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Helicobacter Pylori Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Helicobacter Pylori Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Helicobacter Pylori Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • JAPAN
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • CHINA
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • EUROPE
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Helicobacter Pylori Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Helicobacter Pylori Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • GERMANY
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Helicobacter Pylori Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Helicobacter Pylori Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • AUSTRALIA
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • INDIA
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Helicobacter Pylori Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Helicobacter Pylori Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Helicobacter Pylori Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Helicobacter Pylori Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030
  • AFRICA
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2015, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2015, 2025 & 2030

IV. COMPETITION